M. C. Abraham and S. Shaham, Death without caspases, caspases without death, Trends in Cell Biology, vol.14, issue.4, pp.184-93, 2004.
DOI : 10.1016/j.tcb.2004.03.002

C. Adrain and S. J. Martin, The mitochondrial apoptosome: a killer unleashed by the cytochrome seas, Trends in Biochemical Sciences, vol.26, issue.6, pp.390-397, 2001.
DOI : 10.1016/S0968-0004(01)01844-8

B. B. Aggarwal, Signalling pathways of the TNF superfamily: a double-edged sword, Nature Reviews Immunology, vol.3, issue.9, pp.745-56, 2003.
DOI : 10.1038/nri1184

M. Ahmad and S. M. Srinivasula, CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP, Cancer Res, vol.57, issue.4, pp.615-624, 1997.

V. Aidinis and D. Plows, Functional analysis of an arthritogenic synovial fibroblast, Arthritis Research & Therapy, vol.5, issue.3, pp.140-57, 2003.
DOI : 10.1186/ar749

D. M. Anderson and E. Maraskovsky, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, vol.390, issue.6656, pp.175-184, 1997.
DOI : 10.1038/36593

H. Asahara and M. Asanuma, High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis, Biochem Mol Biol Int, vol.37, issue.5, pp.827-859, 1995.

H. Asahara and T. Hasunuma, In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis EPHE Banque de Monographies SVT synovium, J Rheumatol, vol.24, issue.3, pp.430-435, 1997.

A. Ashkenazi, Targeting death and decoy receptors of the tumour-necrosis factor superfamily, Nature Reviews Cancer, vol.194, issue.6, pp.420-450, 2002.
DOI : 10.1084/jem.194.10.1441

K. Aupperle and B. Bennett, NF-??B Regulation by I??B Kinase-2 in Rheumatoid Arthritis Synoviocytes, The Journal of Immunology, vol.166, issue.4, pp.2705-2716, 2001.
DOI : 10.4049/jimmunol.166.4.2705

URL : http://www.jimmunol.org/content/jimmunol/166/4/2705.full.pdf

V. Baud and M. Karin, Signal transduction by tumor necrosis factor and its relatives, Trends in Cell Biology, vol.11, issue.9, pp.372-379, 2001.
DOI : 10.1016/S0962-8924(01)02064-5

M. J. Benito and E. Murphy, Increased synovial tissue NF-?B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis, Arthritis & Rheumatism, vol.48, issue.6, pp.1781-1788, 2004.
DOI : 10.1136/ard.61.suppl_2.ii13

J. L. Bodmer and P. Schneider, The molecular architecture of the TNF superfamily, Trends in Biochemical Sciences, vol.27, issue.1, pp.19-26, 2002.
DOI : 10.1016/S0968-0004(01)01995-8

B. Bolon and V. Shalhoub, Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis, Arthritis & Rheumatism, vol.3, issue.12, pp.3121-3156, 2002.
DOI : 10.1172/JCI10763

C. D. Buckley and D. Pilling, Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation, Trends in Immunology, vol.22, issue.4, pp.199-204, 2001.
DOI : 10.1016/S1471-4906(01)01863-4

A. Burlacu, Regulation of apoptosis by Bcl-2 family proteins, Journal of Cellular and Molecular Medicine, vol.95, issue.3, pp.249-57, 2003.
DOI : 10.1101/gad.897601

L. C. Cantley and B. G. Neel, New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway, Proceedings of the National Academy of Sciences, vol.67, issue.1, pp.96-4240, 1999.
DOI : 10.1146/annurev.biochem.67.1.481

URL : http://www.pnas.org/content/96/8/4240.full.pdf

H. S. Cha and K. S. Ahn, Influence of hypoxia on the expression of matrix metalloproteinase-1, -3 and tissue inhibitor of metalloproteinase-1 in rheumatoid synovial fibroblasts, Clin Exp Rheumatol, vol.21, issue.5, pp.593-601, 2003.

F. Chen and V. Castranova, New Insights into the Role of Nuclear Factor-??B in Cell Growth Regulation, The American Journal of Pathology, vol.159, issue.2, pp.387-97, 2001.
DOI : 10.1016/S0002-9440(10)61708-7

J. J. Chou and H. Matsuo, Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment, Cell, vol.94, issue.2, pp.171-80, 1998.
DOI : 10.1016/S0092-8674(00)81417-8

P. Collin-osdoby and L. Rothe, Receptor Activator of NF-??B and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis, Journal of Biological Chemistry, vol.11, issue.23, pp.20659-72, 2001.
DOI : 10.1074/jbc.C000290200

A. P. Cope, Studies of T-cell activation in chronic inflammation, Arthritis Research, vol.4, issue.Suppl 3, pp.197-211, 2002.
DOI : 10.1186/ar557

T. N. Crotti and M. D. Smith, Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis, Annals of the Rheumatic Diseases, vol.61, issue.12, pp.61-1047, 2002.
DOI : 10.1136/ard.61.12.1047

S. M. Dai and K. Nishioka, Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1?? and tumour necrosis factor ??, Annals of the Rheumatic Diseases, vol.63, issue.11, pp.1379-86, 2004.
DOI : 10.1136/ard.2003.018481

URL : http://ard.bmj.com/content/annrheumdis/63/11/1379.full.pdf

M. A. Degli-esposti and W. C. Dougall, The Novel Receptor TRAIL-R4 Induces NF-??B and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain, Immunity, vol.7, issue.6, pp.813-833, 1997.
DOI : 10.1016/S1074-7613(00)80399-4

URL : http://doi.org/10.1016/s1074-7613(00)80399-4

M. A. Degli-esposti and P. J. Smolak, Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family, The Journal of Experimental Medicine, vol.268, issue.7, pp.1165-70, 1997.
DOI : 10.1016/0008-8749(91)90062-G

A. Degterev and M. Boyce, A decade of caspases, Oncogene, vol.22, issue.53, pp.8543-67, 2003.
DOI : 10.1038/sj.onc.1207107

Q. L. Deveraux and J. C. Reed, IAP family proteins---suppressors of apoptosis, Genes & Development, vol.13, issue.3, pp.239-52, 1999.
DOI : 10.1101/gad.13.3.239

D. Cristofano, A. , and P. Kotsi, Impaired Fas Response and Autoimmunity in Pten+/ Mice, Science, vol.285, issue.5436, pp.2122-2127, 1999.
DOI : 10.1126/science.285.5436.2122

C. A. Dinarello, IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family, Journal of Allergy and Clinical Immunology, vol.103, issue.1, pp.11-24, 1999.
DOI : 10.1016/S0091-6749(99)70518-X

C. A. Dinarello, The IL-1 family and inflammatory diseases, Clin Exp Rheumatol, vol.205, pp.1-13, 2002.

S. Dooley and I. Herlitzka, Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis., Annals of the Rheumatic Diseases, vol.55, issue.5, pp.298-304, 1996.
DOI : 10.1136/ard.55.5.298

W. C. Dougall and M. Glaccum, RANK is essential for osteoclast and lymph node development, Genes & Development, vol.13, issue.18, pp.2412-2436, 1999.
DOI : 10.1101/gad.13.18.2412

URL : http://genesdev.cshlp.org/content/13/18/2412.full.pdf

J. C. Edwards, Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis, Arthritis Research, vol.2, issue.5, pp.344-351, 2000.
DOI : 10.1186/ar110

H. Ehrhardt and S. Fulda, TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-??B, Oncogene, vol.22, issue.25, pp.3842-52, 2003.
DOI : 10.1038/sj.onc.1206520

URL : http://www.nature.com/onc/journal/v22/n25/pdf/1206520a.pdf

J. G. Emery and P. Mcdonnell, Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL, Journal of Biological Chemistry, vol.158, issue.23, pp.14363-14370, 1998.
DOI : 10.1016/0092-8674(93)80065-M

M. Feldmann and F. M. Brennan, The Role of TNFα and IL-1 in Rheumatoid Arthritis, Curr Dir Autoimmun, vol.3, pp.188-99, 2001.
DOI : 10.1159/000060522

M. Feldmann and F. M. Brennan, ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS, Annual Review of Immunology, vol.14, issue.1, pp.397-440, 1996.
DOI : 10.1146/annurev.immunol.14.1.397

M. Feldmann and R. N. Maini, Cytokine Blockade in Rheumatoid Arthritis, Adv Exp Med Biol, vol.490, pp.119-146, 2001.
DOI : 10.1007/978-1-4615-1243-1_13

G. S. Firestein, Evolving concepts of rheumatoid arthritis, Nature, vol.241, issue.6937, pp.356-61, 2003.
DOI : 10.1126/science.3047874

G. S. Firestein and A. M. Manning, Signal transduction and transcription factors in rheumatic disease, Arthritis & Rheumatism, vol.380, issue.83, pp.609-630, 1999.
DOI : 10.1038/380630a0

URL : http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I/pdf

G. S. Firestein and K. Nguyen, Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium, Am J Pathol, vol.149, issue.6, pp.2143-51, 1996.

T. F. Franke and C. P. Hornik, PI3K/Akt and apoptosis: size matters, Oncogene, vol.22, issue.56, pp.8983-98, 2003.
DOI : 10.1038/sj.onc.1207115

URL : http://www.nature.com/onc/journal/v22/n56/pdf/1207115a.pdf

J. K. Franz and T. Pap, Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis, Arthritis & Rheumatism, vol.43, issue.3, pp.599-607, 2000.
DOI : 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T

J. L. Funk and L. A. Cordaro, Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis., Journal of Clinical Investigation, vol.101, issue.7, pp.1362-71, 1998.
DOI : 10.1172/JCI728

U. Gaur and B. B. Aggarwal, Regulation of proliferation, survival and apoptosis by members of the TNF superfamily, Biochemical Pharmacology, vol.66, issue.8, pp.1403-1411, 2003.
DOI : 10.1016/S0006-2952(03)00490-8

S. R. Goldring, Inflammatory Mediators as Essential Elements in Bone Remodeling, Calcified Tissue International, vol.73, issue.2, pp.97-100, 2003.
DOI : 10.1007/s00223-002-1049-y

W. Gombert and N. J. Borthwick, Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: a selective effect on Bcl-xL expression, Immunology, vol.89, issue.3, pp.397-404, 1996.
DOI : 10.1046/j.1365-2567.1996.d01-759.x

J. A. Gracie and R. J. Forsey, A proinflammatory role for IL-18 in rheumatoid arthritis, Journal of Clinical Investigation, vol.104, issue.10, pp.1393-401, 1999.
DOI : 10.1172/JCI7317

R. Grataroli and D. Vindrieux, Characterization of tumour necrosis factor-??-related apoptosis-inducing ligand and its receptors in the adult human testis, Molecular Human Reproduction, vol.10, issue.2, pp.123-131, 2004.
DOI : 10.1093/molehr/gah016

E. M. Gravallese and Y. Harada, Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis, Am J Pathol, vol.152, issue.4, pp.943-51, 1998.

E. M. Gravallese and C. Manning, Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor, Arthritis & Rheumatism, vol.43, issue.2, pp.250-258, 2000.
DOI : 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P

T. S. Griffith and W. A. Chin, Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells, J Immunol, vol.161, issue.6, pp.2833-2873, 1998.

K. Hadjigogos, The role of free radicals in the pathogenesis of rheumatoid arthritis, Panminerva Med, vol.45, issue.1, pp.7-13, 2003.

Z. Han and D. L. Boyle, Jun N-terminal kinase in rheumatoid arthritis, J Pharmacol Exp Ther, vol.291, issue.1, pp.124-154, 1999.

Z. Han and D. L. Boyle, c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis, Journal of Clinical Investigation, vol.108, issue.1, pp.73-81, 2001.
DOI : 10.1172/JCI12466

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC209341/pdf

M. L. Handel and L. B. Mcmorrow, Nuclear factor???kB in rheumatoid synovium. Localization of P50 and P65, Arthritis & Rheumatism, vol.12, issue.12, pp.1762-70, 1995.
DOI : 10.1128/MCB.11.5.2718

Y. Hashimoto and H. Kakegawa, Significance of Cathepsin B Accumulation in Synovial Fluid of Rheumatoid Arthritis, Biochemical and Biophysical Research Communications, vol.283, issue.2, pp.334-343, 2001.
DOI : 10.1006/bbrc.2001.4787

D. R. Haynes and E. Barg, Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls, Rheumatology, vol.42, issue.1, pp.123-157, 2003.
DOI : 10.1093/rheumatology/keg047

URL : https://academic.oup.com/rheumatology/article-pdf/42/1/123/5036777/420123.pdf

D. R. Haynes and T. N. Crotti, Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint, Rheumatology, vol.40, issue.6, pp.623-653, 2001.
DOI : 10.1093/rheumatology/40.6.623

E. Herlaar and Z. Brown, p38 MAPK signalling cascades in inflammatory disease, Molecular Medicine Today, vol.5, issue.10, pp.439-486, 1999.
DOI : 10.1016/S1357-4310(99)01544-0

A. Hirth and A. Skapenko, Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis, Arthritis Research, vol.4, issue.2, pp.117-142, 2002.
DOI : 10.1186/ar391

N. J. Horwood and J. Elliott, Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells, Endocrinology, vol.139, issue.11, pp.4743-4749, 1998.
DOI : 10.1210/endo.139.11.6433

W. S. Hou and Z. Li, Cathepsin K Is a Critical Protease in Synovial Fibroblast-Mediated Collagen Degradation, The American Journal of Pathology, vol.159, issue.6, pp.2167-77, 2001.
DOI : 10.1016/S0002-9440(10)63068-4

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850593

K. Ichikawa and W. Liu, TRAIL-R2 (DR5) Mediates Apoptosis of Synovial Fibroblasts in Rheumatoid Arthritis, The Journal of Immunology, vol.171, issue.2, pp.1061-1070, 2003.
DOI : 10.4049/jimmunol.171.2.1061

J. G. Jeong and J. M. Kim, Effects of IL-1?? on gene expression in human rheumatoid synovial fibroblasts, Biochemical and Biophysical Research Communications, vol.324, issue.1, pp.3-7, 2004.
DOI : 10.1016/j.bbrc.2004.09.011

J. D. Ji and H. Cheon, Effects of Peroxisome Proliferator-activated Receptor-?? (PPAR-??) on the Expression of Inflammatory Cytokines and Apoptosis Induction in Rheumatoid Synovial Fibroblasts and Monocytes, Journal of Autoimmunity, vol.17, issue.3, pp.215-236, 2001.
DOI : 10.1006/jaut.2001.0542

M. Jo and T. H. Kim, Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosisinducing ligand, Nat Med, vol.6, issue.5, pp.564-571, 2000.

D. M. Jue and K. I. Jeon, Nuclear factor ??B (NF-??B) pathway as a therapeutic target in rheumatoid arthritis, Journal of Korean Medical Science, vol.14, issue.3, pp.231-239, 1999.
DOI : 10.3346/jkms.1999.14.3.231

K. Kanbe and T. Takemura, Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis, The Journal of Bone and Joint Surgery, vol.86, issue.2, pp.296-300, 2004.
DOI : 10.1302/0301-620X.86B2.14474

Y. C. Kang and K. M. Kim, Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation, Cell Death and Differentiation, vol.11, issue.12, pp.1287-98, 2004.
DOI : 10.1038/sj.cdd.4401489

P. V. Kasperkovitz and T. C. Timmer, Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: Evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis, Arthritis & Rheumatism, vol.47, issue.2, pp.430-471, 2005.
DOI : 10.4081/836

T. Kataoka and R. C. Budd, The caspase-8 inhibitor FLIP promotes activation of NF-??B and Erk signaling pathways, Current Biology, vol.10, issue.11, pp.640-648, 2000.
DOI : 10.1016/S0960-9822(00)00512-1

S. K. Kelley and A. Ashkenazi, Targeting death receptors in cancer with Apo2L/TRAIL, Current Opinion in Pharmacology, vol.4, issue.4, pp.333-342, 2004.
DOI : 10.1016/j.coph.2004.02.006

F. C. Kimberley and G. R. Screaton, Following a TRAIL: Update on a ligand and its five receptors, Cell Research, vol.1644, issue.5, pp.359-72, 2004.
DOI : 10.1073/pnas.96.20.10964

R. W. Kinne and R. Brauer, Macrophages in rheumatoid arthritis, Arthritis Research, vol.2, issue.3, pp.189-202, 2000.
DOI : 10.1186/ar86

F. C. Kischkel and D. A. Lawrence, Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5, Immunity, vol.12, issue.6, pp.611-631, 2000.
DOI : 10.1016/S1074-7613(00)80212-5

A. Klinkhoff, Biological Agents for Rheumatoid Arthritis, Drugs, vol.44, issue.5, pp.1267-83, 2004.
DOI : 10.2165/00003495-200464120-00001

Y. Y. Kong and U. Feige, Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature, vol.402, issue.6763supp, pp.304-313, 1999.
DOI : 10.1038/46303

Y. Y. Kong and H. Yoshida, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis, Nature, vol.397, issue.6717, pp.315-338, 1999.

S. Kotake and N. Udagawa, Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients, Arthritis & Rheumatism, vol.247, issue.5, pp.1003-1015, 2001.
DOI : 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#

O. Kudo and A. Sabokbar, Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism, Bone, vol.32, issue.1, pp.1-7, 2003.
DOI : 10.1016/S8756-3282(02)00915-8

M. Kurowska and W. Rudnicka, Fibroblast-Like Synoviocytes from Rheumatoid Arthritis Patients Express Functional IL-15 Receptor Complex: Endogenous IL-15 in Autocrine Fashion Enhances Cell Proliferation and Expression of Bcl-xL and Bcl-2, The Journal of Immunology, vol.169, issue.4, pp.1760-1767, 2002.
DOI : 10.4049/jimmunol.169.4.1760

J. M. Kyriakis and J. Avruch, Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation, Physiol Rev, vol.81, issue.2, pp.807-69, 2001.

D. L. Lacey and E. Timms, Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation, Cell, vol.93, issue.2, pp.165-76, 1998.
DOI : 10.1016/S0092-8674(00)81569-X

URL : http://doi.org/10.1016/s0092-8674(00)81569-x

D. Lallemand and G. Spyrou, Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts, Oncogene, vol.14, issue.7, pp.819-849, 1997.
DOI : 10.1038/sj.onc.1200901

S. E. Lamhamedi-cherradi and S. Zheng, Critical Roles of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Type 1 Diabetes, Diabetes, vol.52, issue.9, pp.2274-2282, 2003.
DOI : 10.2337/diabetes.52.9.2274

S. E. Lamhamedi-cherradi and S. J. Zheng, Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL???/??? mice, Nature Immunology, vol.4, issue.3, pp.255-60, 2003.
DOI : 10.1038/ni894

D. Lawrence and Z. Shahrokh, Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions, Nat Med EPHE Banque de Monographies SVT, vol.7, issue.4, pp.383-388, 2001.

H. Leblanc and D. Lawrence, Tumor-cell resistance to death receptor???induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax, Nature Medicine, vol.8, issue.3, pp.274-81, 2002.
DOI : 10.1038/nm0302-274

H. N. Leblanc and A. Ashkenazi, Apo2L/TRAIL and its death and decoy receptors, Cell Death and Differentiation, vol.10, issue.1, pp.66-75, 2003.
DOI : 10.1038/sj.cdd.4401187

J. Lehmann and A. Jungel, Grafting of Fibroblasts Isolated from the Synovial Membrane of Rheumatoid Arthritis (RA) Patients Induces Chronic Arthritis in SCID Mice???A Novel Model for Studying the Arthritogenic Role of RA Fibroblasts In Vivo, Journal of Autoimmunity, vol.15, issue.3, pp.301-314, 2000.
DOI : 10.1006/jaut.2000.0435

F. Y. Liew and I. B. Mcinnes, The role of innate mediators in inflammatory response, Molecular Immunology, vol.38, issue.12-13, pp.12-13, 2002.
DOI : 10.1016/S0161-5890(02)00014-7

H. Liu and H. Perlman, Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages, The Journal of Experimental Medicine, vol.92, issue.2, pp.113-139, 2001.
DOI : 10.1126/science.290.5493.989

H. Liu and R. M. Pope, Phagocytes: mechanisms of inflammation and tissue destruction, Rheumatic Disease Clinics of North America, vol.30, issue.1, pp.19-39, 2004.
DOI : 10.1016/S0889-857X(03)00107-8

Z. Liu and X. Xu, CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis, Journal of Clinical Investigation, vol.112, issue.9, pp.1332-1373, 2003.
DOI : 10.1172/JCI200319209

J. D. Lunemann and S. Waiczies, Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells, The Journal of Immunology, vol.168, issue.10, pp.4881-4889, 2002.
DOI : 10.4049/jimmunol.168.10.4881

S. S. Makarov, NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction, Arthritis Research, vol.3, issue.4, pp.200-206, 2001.
DOI : 10.1186/ar300

S. Malagarie-cazenave and N. Andrieu-abadie, Sphingolipid signalling: molecular basis and role in TNF-[alpha]-induced cell death, Expert Reviews in Molecular Medicine, vol.4, issue.28, pp.1-15, 2002.
DOI : 10.1017/S146239940200546X

X. Mariette, The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseases, Joint Bone Spine, vol.71, issue.5, pp.357-60, 2004.
DOI : 10.1016/j.jbspin.2003.12.005

S. Matsumoto and U. Muller-ladner, Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts, J Rheumatol, vol.23, issue.8, pp.1345-52, 1996.

H. Matsuno and K. Yudoh, The role of TNF????? in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera, Rheumatology, vol.41, issue.3, pp.329-366, 2002.
DOI : 10.1093/rheumatology/41.3.329

V. V. Michael and K. E. Alisa, Cell cycle implications in the pathogenesis of rheumatoid arthritis, Front Biosci, vol.5, pp.594-601, 2000.

H. Min and S. Morony, Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis, The Journal of Experimental Medicine, vol.60, issue.4, pp.463-74, 2000.
DOI : 10.1038/386078a0

URL : http://jem.rupress.org/content/jem/192/4/463.full.pdf

A. Minden and A. Lin, c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases., Molecular and Cellular Biology, vol.14, issue.10, pp.6683-6691, 1994.
DOI : 10.1128/MCB.14.10.6683

T. Mino and E. Sugiyama, Interleukin-1? and tumor necrosis factor ? synergistically stimulate prostaglandin E2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts, Arthritis & Rheumatism, vol.272, issue.11, pp.2004-2017, 1998.
DOI : 10.1002/1529-0131(199811)41:11<2004::AID-ART16>3.0.CO;2-Z

M. E. Miranda-carus and A. Balsa, Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally active, Arthritis & Rheumatism, vol.50, issue.9, pp.2786-93, 2004.
DOI : 10.1002/art.20203

T. Miyashita and A. Kawakami, Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells, Clinical & Experimental Immunology, vol.191, issue.2, pp.430-436, 2004.
DOI : 10.4049/jimmunol.171.2.1061

T. Miyashita and A. Kawakami, Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells, Biochemical and Biophysical Research Communications, vol.312, issue.2, pp.397-404, 2003.
DOI : 10.1016/j.bbrc.2003.10.141

J. C. Morel and C. C. Park, Interleukin-18 Induces Rheumatoid Arthritis Synovial Fibroblast CXC Chemokine Production through NF??B Activation, Laboratory Investigation, vol.273, issue.10, pp.1371-83, 2001.
DOI : 10.1073/pnas.94.8.3948

URL : http://www.nature.com/labinvest/journal/v81/n10/pdf/3780351a.pdf

J. C. Morel and C. C. Park, A Novel Role for Interleukin-18 in Adhesion Molecule Induction through NF??B and Phosphatidylinositol (PI) 3-Kinase-dependent Signal Transduction Pathways, Journal of Biological Chemistry, vol.19, issue.40, pp.37069-75, 2001.
DOI : 10.1128/MCB.19.7.4798

Y. Morita and N. Kashihara, Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation, Annals of the Rheumatic Diseases, vol.57, issue.2, pp.122-126, 1998.
DOI : 10.1136/ard.57.2.122

URL : http://ard.bmj.com/content/annrheumdis/57/2/122.full.pdf

U. Muller-ladner and J. Kriegsmann, Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice, Am J Pathol, vol.149, issue.5, pp.1607-1622, 1996.

U. Muller-ladner and J. Kriegsmann, Oncogenes in rheumatoid arthritis, Rheum Dis Clin North Am, vol.21, issue.3, pp.675-90, 1995.

T. Naka and N. Nishimoto, The paradigm of IL-6: from basic science to medicine, Arthritis Research, vol.4, issue.Suppl 3, pp.233-275, 2002.
DOI : 10.1186/ar565

E. Banque-de-monographies, S. Nakano, K. , and Y. Okada, Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts, Arthritis Rheum, vol.50, issue.8, pp.2450-2458, 2004.

T. Nakashima and Y. Kobayashi, Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-??B Ligand: Modulation of the Expression by Osteotropic Factors and Cytokines, Biochemical and Biophysical Research Communications, vol.275, issue.3, pp.768-75, 2000.
DOI : 10.1006/bbrc.2000.3379

L. Neff and M. Zeisel, ERK 1/2- and JNKs-dependent Synthesis of Interleukins 6 and 8 by Fibroblast-like Synoviocytes Stimulated with Protein I/II, a Modulin from Oral Streptococci, Requires Focal Adhesion Kinase, Journal of Biological Chemistry, vol.14, issue.30, pp.27721-27729, 2003.
DOI : 10.1074/jbc.272.46.29083

Y. Niki and H. Yamada, Membrane-Associated IL-1 Contributes to Chronic Synovitis and Cartilage Destruction in Human IL-1?? Transgenic Mice, The Journal of Immunology, vol.172, issue.1, pp.577-84, 2004.
DOI : 10.4049/jimmunol.172.1.577

URL : http://www.jimmunol.org/content/jimmunol/172/1/577.full.pdf

Y. Nonomura and H. Kohsaka, Gene Transfer of a Cell Cycle Modulator Exerts Anti-Inflammatory Effects in the Treatment of Arthritis, The Journal of Immunology, vol.171, issue.9, pp.4913-4922, 2003.
DOI : 10.4049/jimmunol.171.9.4913

Y. Ogawa and M. Ohtsuki, Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells, Arthritis & Rheumatism, vol.40, issue.12, pp.3350-3358, 2003.
DOI : 10.1002/art.11322

L. J. Pagliari and H. Perlman, Macrophages Require Constitutive NF-kappa B Activation To Maintain A1 Expression and Mitochondrial Homeostasis, Molecular and Cellular Biology, vol.20, issue.23, pp.8855-65, 2000.
DOI : 10.1128/MCB.20.23.8855-8865.2000

URL : http://mcb.asm.org/content/20/23/8855.full.pdf

G. Palao and . Santiago, Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis, Arthritis & Rheumatism, vol.46, issue.Suppl 9, pp.2803-2813, 2004.
DOI : 10.1016/S0092-8674(03)00521-X

T. Pap and J. K. Franz, Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction, Arthritis Research, vol.2, issue.1, pp.59-64, 2000.
DOI : 10.1186/ar69

Y. W. Park and J. D. Ji, Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis???inducing ligand (TRAIL)???induced apoptosis, Scandinavian Journal of Rheumatology, vol.7, issue.14, pp.356-63, 2003.
DOI : 10.1038/86397

H. Perlman and C. Georganas, Bcl-2 Expression in Synovial Fibroblasts Is Essential for Maintaining Mitochondrial Homeostasis and Cell Viability, The Journal of Immunology, vol.164, issue.10, pp.5227-5262, 2000.
DOI : 10.4049/jimmunol.164.10.5227

URL : http://www.jimmunol.org/content/jimmunol/164/10/5227.full.pdf

H. Perlman and N. Nguyen, Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3, Arthritis & Rheumatism, vol.53, issue.11, pp.3096-101, 2003.
DOI : 10.1002/art.11302

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.11302/pdf

H. Perlman and L. J. Pagliari, Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1?-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis, Arthritis & Rheumatism, vol.95, issue.1, pp.21-30, 2001.
DOI : 10.1073/pnas.95.23.13859

URL : http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8/pdf

A. R. Pettit and H. Ji, TRANCE/RANKL Knockout Mice Are Protected from Bone Erosion in a Serum Transfer Model of Arthritis, The American Journal of Pathology, vol.159, issue.5, pp.1689-99, 2001.
DOI : 10.1016/S0002-9440(10)63016-7

C. M. Pfarr and F. Mechta, Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras, Cell, vol.76, issue.4, pp.747-60, 1994.
DOI : 10.1016/0092-8674(94)90513-4

D. Pilling and A. N. Akbar, Interferon-?? mediates stromal cell rescue of T cells from apoptosis, European Journal of Immunology, vol.26, issue.3, pp.1041-50, 1999.
DOI : 10.1002/eji.1830260329

Z. Qu and C. H. Garcia, Local Proliferation of Fibroblast-Like Synoviocytes Contributes to Synovial Hyperplasia, Arthritis & Rheumatism, vol.83, issue.2, pp.212-232, 1994.
DOI : 10.1093/ajcp/94.6.734

R. Ravi and G. C. Bedi, Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-??B, Nature Cell Biology, vol.3, issue.4, pp.409-425, 2001.
DOI : 10.1038/35070096

C. Ritchlin, Fibroblast biology Effector signals released by the synovial fibroblast in arthritis, Arthritis Research, vol.2, issue.5, pp.356-60, 2000.
DOI : 10.1186/ar112

A. Rivollier and M. Mazzorana, Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment, Blood, vol.104, issue.13, pp.4029-4066, 2004.
DOI : 10.1182/blood-2004-01-0041

L. Roberts and G. J. Mccoll, Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis, Internal Medicine Journal, vol.60, issue.12, pp.687-93, 2004.
DOI : 10.1016/S0140-6736(01)05497-6

H. K. Ronday and W. H. Van-der-laan, Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis, Rheumatology, vol.40, issue.1, pp.55-61, 2001.
DOI : 10.1093/rheumatology/40.1.55

P. P. Roux and J. Blenis, ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions, Microbiology and Molecular Biology Reviews, vol.68, issue.2, pp.320-364, 2004.
DOI : 10.1128/MMBR.68.2.320-344.2004

E. Banque-de-monographies, S. Salmon, M. , and D. Scheel-toellner, Inhibition of T cell apoptosis in the rheumatoid synovium, J Clin Invest, vol.99, issue.3, pp.439-485, 1997.

J. Schedel and R. E. Gay, FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis, Arthritis & Rheumatism, vol.7, issue.6, pp.1512-1520, 2002.
DOI : 10.1016/S1074-7613(00)80401-X

G. Schett and M. Tohidast-akrad, Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis, Arthritis & Rheumatism, vol.18, issue.11, pp.2501-2513, 2000.
DOI : 10.1002/bies.950180507

P. Schneider and D. Olson, Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL), Journal of Biological Chemistry, vol.162, issue.7, pp.5444-54, 2003.
DOI : 10.1016/S1074-7613(00)80399-4

P. Schneider and M. Thome, TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-??B, Immunity, vol.7, issue.6, pp.831-837, 1997.
DOI : 10.1016/S1074-7613(00)80401-X

URL : http://doi.org/10.1016/s1074-7613(00)80401-x

D. R. Schultz, W. J. Harrington, and J. , Apoptosis: Programmed cell death at a molecular level, Seminars in Arthritis and Rheumatism, vol.32, issue.6, pp.345-69, 2003.
DOI : 10.1053/sarh.2003.50005

P. Secchiero and A. Gonelli, TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways, Circulation, vol.107, issue.17, pp.2250-2256, 2003.
DOI : 10.1161/01.CIR.0000062702.60708.C4

P. Secchiero and A. Gonelli, Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway, Blood, vol.100, issue.7, pp.2421-2430, 2002.
DOI : 10.1182/blood-2002-01-0047

L. M. Sedger and D. M. Shows, IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression, J Immunol, vol.163, issue.2, pp.920-926, 1999.

C. A. Seemayer and S. Kuchen, p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion, Annals of the Rheumatic Diseases, vol.62, issue.12, pp.1139-1183, 2003.
DOI : 10.1136/ard.2003.007401

E. Shaulian and M. Karin, AP-1 in cell proliferation and survival, Oncogene, vol.20, issue.19, pp.2390-400, 2001.
DOI : 10.1038/sj.onc.1204383

URL : http://www.nature.com/onc/journal/v20/n19/pdf/1204383a.pdf

J. P. Sheridan and S. A. Marsters, Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors, Science, vol.277, issue.5327, pp.818-839, 1997.
DOI : 10.1126/science.277.5327.818

Y. Shigeyama and T. Pap, Expression of osteoclast differentiation factor in rheumatoid arthritis, Arthritis & Rheumatism, vol.139, issue.11, pp.2523-2553, 2000.
DOI : 10.1210/endo.139.11.6433

T. S. Soderstrom and M. Poukkula, Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling in Activated T Cells Abrogates TRAIL-Induced Apoptosis Upstream of the Mitochondrial Amplification Loop and Caspase-8, The Journal of Immunology, vol.169, issue.6, pp.2851-60, 2002.
DOI : 10.4049/jimmunol.169.6.2851

K. Song and Y. Chen, Tumor Necrosis Factor???Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression, The Journal of Experimental Medicine, vol.155, issue.7, pp.1095-104, 2000.
DOI : 10.1016/S1074-7613(00)80400-8

M. Sugiyama and T. Tsukazaki, Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis., Annals of the Rheumatic Diseases, vol.55, issue.7, pp.442-451, 1996.
DOI : 10.1136/ard.55.7.442

S. E. Sweeney and G. S. Firestein, Rheumatoid arthritis: regulation of synovial inflammation, The International Journal of Biochemistry & Cell Biology, vol.36, issue.3, pp.372-380, 2004.
DOI : 10.1016/S1357-2725(03)00259-0

H. Takayanagi and H. Iizuka, Involvement of receptor activator of nuclear factor ??B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis, Arthritis & Rheumatism, vol.43, issue.2, pp.259-69, 2000.
DOI : 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W

H. Takayanagi and H. Oda, A New Mechanism of Bone Destruction in Rheumatoid Arthritis: Synovial Fibroblasts Induce Osteoclastogenesis, Biochemical and Biophysical Research Communications, vol.240, issue.2, pp.279-86, 1997.
DOI : 10.1006/bbrc.1997.7404

K. Takeda and M. J. Smyth, Critical Role for Tumor Necrosis Factor???related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development, The Journal of Experimental Medicine, vol.161, issue.2, pp.161-170, 2002.
DOI : 10.1038/35074122

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193611

H. Thakkar and X. Chen, Pro-survival Function of Akt/Protein Kinase B in Prostate Cancer Cells, Journal of Biological Chemistry, vol.58, issue.42, pp.38361-38370, 2001.
DOI : 10.1101/sqb.1999.64.343

L. E. Theill and W. J. Boyle, RANK: T Cells, Bone Loss, and Mammalian Evolution, Annual Review of Immunology, vol.20, issue.1, pp.795-823, 2002.
DOI : 10.1146/annurev.immunol.20.100301.064753

T. C. Tolboom and E. Pieterman, Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10, Annals of the Rheumatic Diseases, vol.61, issue.11, pp.61-975, 2002.
DOI : 10.1136/ard.61.11.975

A. Truneh and S. Sharma, Temperature-sensitive Differential Affinity of TRAIL for Its Receptors, Journal of Biological Chemistry, vol.5, issue.30, pp.23319-23344, 2000.
DOI : 10.1038/14935

H. F. Tsai and J. J. Lai, Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: Possible role in T cell activation in systemic lupus erythematosus, Arthritis & Rheumatism, vol.166, issue.2, pp.629-668, 2004.
DOI : 10.4049/jimmunol.166.2.1314

G. C. Tsokos and M. Tsokos, The TRAIL to arthritis, Journal of Clinical Investigation, vol.112, issue.9, pp.1315-1322, 2003.
DOI : 10.1172/JCI200320297

URL : http://www.jci.org/articles/view/20297/files/pdf

N. Udagawa and S. Kotake, The molecular mechanism of osteoclastogenesis in rheumatoid arthritis, Arthritis Research, vol.4, issue.5, pp.281-290, 2002.
DOI : 10.1186/ar431

E. Banque-de-monographies, S. Van-dam, H. , and M. Castellazzi, Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis, Oncogene, vol.20, pp.2453-64, 2001.

D. Vindrieux and M. Devonec, Identification of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and its receptors in adult rat ventral prostate, Molecular and Cellular Endocrinology, vol.198, issue.1-2, pp.115-136, 2002.
DOI : 10.1016/S0303-7207(02)00407-0

S. Wakisaka and N. Suzuki, Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro, Arthritis & Rheumatism, vol.41, issue.3, pp.470-81, 1998.
DOI : 10.1002/1529-0131(199803)41:3<470::AID-ART14>3.3.CO;2-F

S. Wakisaka and N. Suzuki, Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA), Clinical and Experimental Immunology, vol.263, issue.1, pp.119-147, 1998.
DOI : 10.1083/jcb.119.3.493

H. Walczak and R. E. Miller, Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo, Nat Med, vol.5, issue.2, pp.157-63, 1999.

S. R. Wiley and K. Schooley, Identification and characterization of a new member of the TNF family that induces apoptosis, Immunity, vol.3, issue.6, pp.673-82, 1995.
DOI : 10.1016/1074-7613(95)90057-8

B. R. Wong and J. Rho, TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells, Journal of Biological Chemistry, vol.264, issue.40, pp.25190-25194, 1997.
DOI : 10.1073/pnas.93.26.15164

C. Xue and M. Takahashi, Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes, Annals of the Rheumatic Diseases, vol.56, issue.4, pp.262-269, 1997.
DOI : 10.1136/ard.56.4.262

H. Yagita and K. Takeda, TRAIL and its receptors as targets for cancer therapy, Cancer Science, vol.166, issue.10, pp.777-83, 2004.
DOI : 10.4049/jimmunol.166.2.1314

A. Yamamoto and A. Fukuda, Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts, Arthritis & Rheumatism, vol.148, issue.9, pp.2682-92, 2003.
DOI : 10.1128/MCB.14.8.5441

Y. Yamanishi and D. L. Boyle, Regulation of Joint Destruction and Inflammation by p53 in Collagen-Induced Arthritis, The American Journal of Pathology, vol.160, issue.1, pp.123-153, 2002.
DOI : 10.1016/S0002-9440(10)64356-8

S. Yamasaki and A. Kawakami, Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells, Annals of the Rheumatic Diseases, vol.60, issue.7, pp.678-84, 2001.
DOI : 10.1136/ard.60.7.678

Q. Yao and S. Wang, Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium, Gene Therapy, vol.10, issue.12, pp.1055-60, 2003.
DOI : 10.1038/sj.gt.3301881

H. Yasuda and N. Shima, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proceedings of the National Academy of Sciences, vol.3, issue.11, pp.3597-602, 1998.
DOI : 10.1038/nm1197-1285

URL : http://www.pnas.org/content/95/7/3597.full.pdf

H. G. Zhang and N. Huang, Gene therapy that inhibits nuclear translocation of nuclear factor ??B results in tumor necrosis factor ?????induced apoptosis of human synovial fibroblasts, Arthritis & Rheumatism, vol.43, issue.5, pp.1094-105, 2000.
DOI : 10.1002/1529-0131(200005)43:5<1094::AID-ANR20>3.0.CO;2-V

H. G. Zhang and Y. Wang, Regulation of tumor necrosis factor ?-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt, Arthritis & Rheumatism, vol.41, issue.7, pp.1555-67, 2001.
DOI : 10.1002/1529-0131(199801)41:1<139::AID-ART17>3.0.CO;2-T

L. Zhang and B. Fang, Mechanisms of resistance to TRAIL-induced apoptosis in cancer, Cancer Gene Therapy, vol.12, issue.3, pp.228-265, 2005.
DOI : 10.1038/sj.cgt.7700792

X. D. Zhang and T. Nguyen, Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types, FEBS Letters, vol.161, issue.3, pp.193-202, 2000.
DOI : 10.1038/40657

M. Ziolkowska and M. Kurowska, High levels of osteoprotegerin and soluble receptor activator of nuclear factor ?B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor ? treatment, Arthritis & Rheumatism, vol.43, issue.7, pp.1744-53, 2002.
DOI : 10.1002/art.10388

J. Zwerina and S. Hayer, Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: Effects on synovial inflammation, bone erosion, and cartilage destruction, Arthritis & Rheumatism, vol.44, issue.1, pp.277-90, 2004.
DOI : 10.1016/S0002-9440(10)63016-7

C. Duyckaerts, P. Fouret, and . Hauw, Anatomie pathologique-Chap3-Inflammation, 2002.

. Polycopié, Module-8-Réaction inflammatoire -Aspects biologiques et cliniques